Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

Share Price is delayed by 15 minutes
Get Live Data
142.50    -4.00 (-2.73%)
Bid:
140.00
Ask:
145.00
Spread: 5.00 (3.571%)
Market Cap: £167.18m
SUP Live PriceLast checked at - London Stock Exchange

Intraday Supreme Plc Share Chart

Block Admission Return

2 Jan 2026 07:00

RNS Number : 3619N
Supreme PLC
02 January 2026
 

2 January 2026

 

Supreme plc

("Supreme", the "Company" or the "Group")

 

Block Admission Return

 

Supreme (AIM:SUP), a leading manufacturer, supplier and brand owner of fast-moving consumer goods, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements which were announced on 19 January 2023:

 

Name of Company

Supreme PLC

Name of Scheme

Supreme 2018 EMI Scheme

Supreme 2018 Unapproved Scheme

Supreme 2021 CSOP Scheme

Supreme 2021 Unapproved Scheme

Supreme 2021 Sharesave Scheme

Period of Return (from/to)

1 July 2025 to 31 December 2025

Number and class of securities not issued at the start of the period under the scheme

470,858 ordinary shares of £0.10 each ("Ordinary Shares"), as follows:

- 7,626 Ordinary Shares under the Supreme 2018 EMI Scheme

 

- 181,026 Ordinary Shares under the Supreme 2021 CSOP Scheme

 

- 54,596 Ordinary Shares under the Supreme 2021 Unapproved Scheme

 

- 227,610 Ordinary Shares under the Supreme 2021 Sharesave Scheme

 

Number of securities admitted during the period

None

Number of securities issued under the scheme during the period

None

 

Balance under the scheme of securities not yet issued at the end of the period

470,858 Ordinary Shares

Number and class of shares originally admitted and the date of admission

1,989,587 Ordinary Shares on 20 January 2023

 

In compliance with the FCA's Disclosure Guidance and Transparency Rules (the "Rules"), the Company announces that, as at the date of this announcement, it has 117,317,803 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury and all of the Ordinary Shares have equal voting rights.

 

The figure of 117,317,803 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

 

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

Shore Capital (Nominated Adviser and Joint Broker)

Mark Percy / David Coaten / George Payne - Corporate Advisory

Ben Canning - Corporate Broking

 

+44 (0)20 7408 4090

Zeus (Joint Broker)

Jordan Warburton / Emma Burn - Investment Banking

Benjamin Robertson - Corporate Broking

 

+44 (0)161 831 1512

Vigo Consulting (Financial PR & Investor Relations)

Jeremy Garcia / Peter Jacob

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

 

About Supreme

 

Supreme supplies products across three operating divisions: Vaping (previously known as 'Vaping' and 'Branded Distribution'), Drinks & Wellness ('Sports Nutrition & Wellness' combined with Typhoo Tea, Clearly Drinks and the newly acquired SlimFast brand), and Electricals & Household (previously 'Batteries' and 'Lighting', also including the recently acquired 1001 cleaning brand). The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,000 active business accounts with around 55,000 retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsbury's, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland, Waitrose, Aldi and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also built a strong portfolio of in-house brands, most notably 88Vape. The Company has a growing footprint in Sports Nutrition & Wellness via its principal Sci-MX brand and has recently expanded into the soft drinks and hot beverages markets with the acquisitions of Typhoo Tea and Clearly Drinks and now into weight management through SlimFast, one of the UK's leading meal replacement brands.

 

https://investors.supreme.co.uk/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFDIFIFEISEFE
Date   Source Headline
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20247:00 amRNSCommencement of Share Buyback Programme
29th Jan 20242:42 pmRNSMarket and Trading Update and Share Buyback
5th Jan 20247:00 amRNSAcquisition of protein manufacturing assets
2nd Jan 20247:00 amRNSBlock Admission Return
29th Dec 20237:00 amRNSTotal Voting Rights
1st Dec 20238:58 amRNSGrant of Options and Director Dealing
28th Nov 20237:00 amRNSHalf-year Results
31st Oct 20237:00 amRNSTotal Voting Rights
23rd Oct 20237:00 amRNSAppointment of Nomad and Joint Brokers
18th Oct 20237:01 amRNSVaping Category Update
18th Oct 20237:00 amRNSTrading Statement & Notice of Results
4th Oct 202310:50 amRNSDirector Share Purchase
26th Sep 202312:07 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Trading Statement
13th Sep 20238:31 amRNSResponse to Media Speculation
23rd Aug 20237:00 amRNSAvailability of Annual Report & Notice of AGM
5th Jul 20237:01 amRNSSignificant Vaping Distribution Appointment
5th Jul 20237:00 amRNSFinal Results
3rd Jul 20237:00 amRNSBlock Admission of Shares
19th Jun 20239:30 amRNSNotice of Results & Investor Presentation
15th May 20233:07 pmRNSDirector Share Purchase
28th Apr 20237:00 amRNSTotal Voting Rights
20th Apr 202311:56 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSYear End Trading Update
31st Mar 20237:00 amRNSTotal Voting Rights
14th Mar 20232:30 pmRNSDisposal of the IP of T-Juice
28th Feb 202312:34 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSBlock Admission of Shares
13th Jan 20237:00 amRNSHolding(s) in Company
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSStrong Q3 Trading
29th Nov 20227:00 amRNSHalf-year Results
24th Oct 20227:00 amRNSTrading Update and Notice of Results
15th Sep 20225:08 pmRNSResult of AGM
15th Sep 20227:00 amRNSAGM Statement
22nd Aug 202211:06 amRNSSecond Price Monitoring Extn
22nd Aug 202211:00 amRNSPrice Monitoring Extension
15th Aug 20227:00 amRNSAvailability of Annual Report & Notice of AGM
9th Aug 20227:00 amRNSAcquisition of Cuts Ice/Flavour Core trade/assets
8th Aug 20227:00 amRNSGrant of performance share awards to a PDMR
25th Jul 20227:00 amRNSDirector Share Purchase
18th Jul 20224:41 pmRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.